We are updating our Privacy Policy and Terms and Conditions to help you clearly understand how your personal information is collected, stored and managed. Learn More
Menu Back to Event-Details

Collaborative Frameworks and Public Private Partnerships as Drivers of Innovation

Track:
Medicines of the Future: What Will Innovation Need and Bring?

Day & Time:
April 19, 8:30AM - 10:00AM (Central Europe Standard Time)

Session Number:
S0304

Room Number:
Boston 3

Type:
Session

Title:
Collaborative Frameworks and Public Private Partnerships as Drivers of Innovation

Chair(s):
Corinne de Vries, PhD, MA, MSc, FISPE
Head of Science and Innovation Support (ad interim)
European Medicines Agency, United Kingdom

Description:
A condensed overview of the current state of play when it comes to PPP s from an EU perspective and their key role in bringing together the latest research and cutting-edge technology to boost innovation and entrepreneurship in the pharmaceutical sector, to meet the challenges faced by patients and society as a whole.

Presentation(s) & Speaker(s):
Accelerating Innovation through Public Private Partnerships: IMI as an Example
Pierre Meulien, PhD
Executive Director
Innovative Medicines Initiative, Belgium

Advancing Innovation with Novel Methodologies - C-Path’s PPP Approach to Achieving Regulatory Acceptance
Martha Ann Brumfield, PhD
President and Chief Executive Officer
Critical Path Institute, United States

The IMI SAFE-T Consortium: Engaging with Regulators to Enhance Success and Opportunities of Public Private Partnerships
Gerd Kullak-Ublick
Global Head, Mechanistic Safety, Chief Medical Office and Patient Safety
Novartis, Switzerland